Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer
Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds
NCCN Updates Myeloma Clinical Practice Guidelines
Wilmot Researchers Study Combination for Lymphoma
Colorado Researchers Study Massage To Reduce Symptoms
Longer Infusion More Effective For Pancreatic Cancer
Bladder Cancer Survival Rate Rises With Neoadjuvant Chemo
Almost Half of Faculty on IRBs Have Industry Ties, Study Finds
Non-Invasive Test May Detect Lung Cancer In Early Stages
Fish Oil May Help Prevent Weight Loss In Cancer Patients
IARC Finds Betel Quid, Areca Nut Chewing Causes Cancer
Clinical Trials Approved By NCI
Trending Stories
- An opportunity for Trump: Position U.S. cancer science to lead the world
- Former Maryland Governor Larry Hogan to receive Public Service Leadership Award from National Coalition for Cancer Survivorship
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - Grilled by Congress, Kennedy defends NIH and NCI budget cuts, freezes, and RIFs
To avoid “offending” pharma, NCI doesn’t study the causes of early-onset colon cancer, HHS secretary incorrectly alleges - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Kennedy’s claims notwithstanding, NCI clinical trials are delayed, enrollments reduced
NCI’s Steven A. Rosenberg: “Almost all patients are getting delayed by about a month, but then again, we’re turning away more patients.”
